EX-23.1 4 adms-20151231ex231fbc1df.htm EX-23.1 adms_EX23_1

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

       We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-195384) of Adamas Pharmaceuticals, Inc. of our report dated February 23, 2016 relating to the financial statements of Adamas Pharmaceuticals, Inc., which appears in this Form 10-K for the year ended December 31, 2015.

 

/s/ PricewaterhouseCoopers LLP

 

San Jose, California

February 23, 2016